| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.9 |